本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Olema Pharmaceuticals, Inc.

22.59
-1.1600-4.88%
盤後22.590.00000.00%16:10 EST
成交量:85.72萬
成交額:1,968.44萬
市值:17.77億
市盈率:-12.51
高:24.03
開:23.66
低:22.42
收:23.75
52周最高:36.26
52周最低:2.86
股本:7,865.99萬
流通股本:5,314.44萬
量比:0.61
換手率:1.61%
股息:- -
股息率:- -
每股收益(TTM):-1.8064
每股收益(LYR):-2.2041
淨資產收益率:-59.22%
總資產收益率:-34.41%
市淨率:5.78
市盈率(LYR):-10.25

資料載入中...

公司資料

公司名字:
Olema Pharmaceuticals, Inc.
交易所:
NASDAQ
成立時間:
2006
員工人數:
122
公司地址:
780 Brannan Street,San Francisco,California,United States
郵編:
94103
電話:
傳真:
- -
簡介:
Olema Pharmaceuticals, Inc.位於加利福尼亞州的舊金山,於2006年8月7日在特拉華州註冊成立。該公司是一家臨床階段的生物製藥公司,致力於發現,開發和商業化針對女性癌症的下一代靶向療法。

董事

名稱
職位
Sean Bohen
President,Principal Financial Officer,Chief Executive Officer and Director
Ian Clark
Chairperson of the Board
Andrew Rappaport
Director
Cynthia Butitta
Director
Cyrus L. Harmon
Director
Gorjan Hrustanovic
Director
Graham Walmsley
Director
Sandra Horning
Director
Scott Garland
Director
Yi Larson
Director

股東

名稱
職位
Sean Bohen
President,Principal Financial Officer,Chief Executive Officer and Director
David C. Myles
Chief Discovery and Non-Clinical Development Officer
Naseem Zojwalla
Chief Medical Officer
Shawnte M. Mitchell
Chief Legal Officer and Corporate Secretary